CMP : 1,434
Target Price : 1,852
Abbott India (AIL), a 50.44% subsidiary of Abbott Capital India Ltd., UK, is
involved in the manufacture and marketing of pharmaceutical, diagnostic,
nutritional and hospital products. Consolidation of Solvay Pharma India Ltd. (SPIL)
with the company is expected to improve operating efficiencies, leading to
expansion of EBITDA margin and ..